LIMA1 Antikörper (C-Term)
-
- Target Alle LIMA1 Antikörper anzeigen
- LIMA1 (LIM Domain and Actin Binding 1 (LIMA1))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIMA1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-EPLIN Antibody, Affinity Purified
- Homologie
- Mouse
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 700 and C-term
- Isotyp
- IgG
- Top Product
- Discover our top product LIMA1 Primärantikörper
-
-
- Applikationshinweise
-
IP: 2 - 10 μg/mg lysate
WB: 1:1,000 - 1:5,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- LIMA1 (LIM Domain and Actin Binding 1 (LIMA1))
- Andere Bezeichnung
- EPLIN (LIMA1 Produkte)
- Synonyme
- eplin antikoerper, LIMA1 antikoerper, EPLIN antikoerper, MGC146397 antikoerper, SREBP3 antikoerper, 1110021C24Rik antikoerper, 3526402A12Rik antikoerper, D15Ertd366e antikoerper, Eplin antikoerper, LIM domain and actin binding 1 antikoerper, Lima1 antikoerper, LIMA1 antikoerper, lima1 antikoerper
- Hintergrund
- Background: Epithelial protein lost in neoplasm (EPLIN) is a cytoskeleton-associated protein found to be down-regulated in transformed prostate and breast cells. EPLIN is involved in actin dynamics and plays a role in the formation of stable actin filament structures.
- Gen-ID
- 51474
- NCBI Accession
- NP_057441
- UniProt
- Q9UHB6
-